LENZ
LENZ Therapeutics Inc
NASDAQ: LENZ · HEALTHCARE · BIOTECHNOLOGY
$8.98
-0.77% today
Updated 2026-04-30
Market cap
$306.02M
P/E ratio
—
P/S ratio
16.03x
EPS (TTM)
$-2.85
Dividend yield
—
52W range
$8 – $50
Volume
0.9M
LENZ Therapeutics Inc (LENZ) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-2,422.00%
ROE
-33.60%
ROA
-21.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | — | $-109000.00 | — | — | — |
| 2020 | — | $-68.37M | — | — | — |
| 2021 | $0.00 | $-70.76M | — | — | — |
| 2022 | $15.00M | $-10.81M | 100.00% | -69.89% | -72.07% |
| 2023 | $0.00 | $-69.97M | — | — | — |
| 2024 | $0.00 | $-49.77M | — | — | — |
| 2025 | $19.09M | $-82.13M | 97.81% | -477.46% | -430.25% |